Greenwood Capital Associates LLC Bristol Myers Squibb CO Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

A detailed history of Greenwood Capital Associates LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 37,097 shares of BMY stock, worth $2.15 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

37,097

Previous 5,281 602.46%

Holding current value

$2.15 Million

Previous $219,000 776.26%

% of portfolio

0.25%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$39.66 - $51.75 $1.26 Million - $1.65 Million	31,816 Added 602.46%	37,097 $1.92 Million
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $30,227 - $34,272	-630 Reduced 10.66%	5,281 $286,000
Q4 2023 Mar 05, 2024	SELL	$48.48 - $57.85 $38,299 - $45,701	-790 Reduced 11.79%	5,911 $303,000
Q3 2023 Oct 18, 2023	SELL	$57.89 - $64.73 $7.37 Million - $8.24 Million	-127,325 Reduced 95.0%	6,701 $388,000
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $53,834 - $59,775	845 Added 0.63%	134,026 $8.57 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $786,417 - $891,975	11,968 Added 9.87%	133,181 $9.23 Million
Q4 2022 Jan 26, 2023	SELL	$68.48 - $81.09 $38,622 - $45,734	-564 Reduced 0.46%	121,213 $0
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $1,192 - $705,083	9,176 Added 8.15%	121,777 $8.66 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $3.47 Million - $3.83 Million	47,831 Added 73.85%	112,601 $8.67 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $3.98 Million - $4.77 Million	64,770 New	64,770 $4.73 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $6.51 Million - $7.2 Million	-145,933 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $6.58 Million - $7.85 Million	145,933 New	145,933 $6.96 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $2.67 Million - $3.47 Million	-54,845 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $29,250 - $32,992	-530 Reduced 0.96%	54,845 $3.4 Million
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $116,471 - $145,168	2,305 Added 4.34%	55,375 $3.07 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $528,674 - $608,610	-8,823 Reduced 14.26%	53,070 $3.36 Million
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $47,832 - $52,149	-798 Reduced 1.27%	61,893 $3.79 Million
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $3.46 Million - $4 Million	62,691	62,691 $4 Million

Others Institutions Holding BMY

# of Institutions

2,532

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account

Greenwood Capital Associates LLC Bristol Myers Squibb CO Transaction History